A randomized clinical trial considering the effect of vitamin D supplementation on control of disease activity in rheumatoid arthritis patients patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201110016975N1

Enrollment

Registered

2011-10-18

Start date

2011-11-11

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis. Rheumatoid arthritis, unspecified

Interventions

Intervention 1: No intervention will perform in control group. Intervention 2: Twenty five hydroxy Vitamin D tablet 50000 unit each month orally will given for 6 months to intervention group.

Treatment - Drugs

No intervention will perform in control group.

Twenty five hydroxy Vitamin D tablet 50000 unit each month orally will given for 6 months to intervention group.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Exclusion criteria: Use of vitamin D supplements in the past 6 months; pregnancy; liver and kidney disease; treatment with anticonvulsion drugs drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Disease activity. Timepoint: 6 months. Method of measurement: Questionnaire.	—

Secondary

Measure	Time frame
Complications of treatment. Timepoint: Before intervention and every two months. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026